Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
Description
CONCLUSION: This non-exhaustive review illustrates the experience of RFCRPV in identifying and monitoring pharmacovigilance signals related to mRNA vaccines in France during the COVID-19 pandemics, and the crucial role of pharmacological and clinical
